Header Logo

Connection

JOHN LYDON to Antibodies, Monoclonal

Back to Details
This is a "connection" page, showing publications JOHN LYDON has written about Antibodies, Monoclonal.
JOHN LYDON
Connection Strength
0.080
Antibodies, Monoclonal
  1. Targeting the glucose-regulated protein-78 abrogates Pten-null driven AKT activation and endometrioid tumorigenesis. Oncogene. 2015 Oct; 34(43):5418-26.
    View in: PubMed
    Score: 0.080
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.